![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
(MM) | NASDAQ:IDIX | NASDAQ | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 24.50 | 0.00 | 01:00:00 |
Idenix Pharmaceuticals,
Inc.
|
Delaware
|
000-49839
|
45-0478605
|
(State
or Other Juris-
diction
of Incorporation
|
(Commission
File
Number)
|
(IRS
Employer
Identification
No.)
|
60 Hampshire Street
Cambridge, MA
|
02139
|
(Address
of Principal Executive Offices)
|
(Zip
Code)
|
|
(Former
Name or Former Address, if Changed Since Last
Report)
|
Item 8.01.
|
Other
Events.
|
Item 9.01.
|
Financial
Statements and Exhibits.
|
Exhibit No.
|
Description
|
|
5.1
|
Opinion
of Wilmer Cutler Pickering Hale and Dorr LLP
|
|
23.1
|
Consent
of Wilmer Cutler Pickering Hale and Dorr LLP (included in Exhibit
5.1)
|
|
99.1
|
Purchase
Agreement, dated as of August 5, 2009, between the Registrant and Leerink
Swann LLC
|
|
99.2
|
Press
Release, dated August 5,
2009
|
Idenix
Pharmaceuticals, Inc.
|
||
Date:
August 5, 2009
|
By:
|
/s/
Ronald
C. Renaud, Jr.
|
Ronald
C. Renaud, Jr.
|
||
Chief
Financial Officer
|
Exhibit
No.
|
Description
|
|
5.1
|
Opinion
of Wilmer Cutler Pickering Hale and Dorr LLP
|
|
23.1
|
Consent
of Wilmer Cutler Pickering Hale and Dorr LLP (included in Exhibit
5.1)
|
|
99.1
|
Purchase
Agreement, dated as of August 5, 2009, between the Registrant and Leerink
Swann LLC
|
|
99.2
|
Press
Release, dated August 5,
2009
|
1 Year (MM) Chart |
1 Month (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions